Clinical TrialsSearch results
Number of results: 737
- Recruitment status
- Title of the study
- Health Condition
- Primary sponsor
- Date of registration
Other
- A phase I/II study of concurrent chemoradiation with irinotecan hydrochloride(CPT-11) and cisplatin(CDDP) for uterine cervical cancer. (KCOG 0328)
- Uterine cervical cancer
- Kansai Clinical Oncology Group (KCOG)
- 2005-09-16
Other
- A comparing study between open and close of retroperitonium on lymphedema of the lower extremities after surgeries of both uterine cervical and endometrial cancer (a randomized study by multi-institutes)
- uterine cervical and endometrial cancer
- The development reserarch cancer treatments aiming improvement of QOL
- 2011-12-31
Other
- A phase I/II study of concurrent chemoradiotherapy with irinotecan for advanced or recurrent uterine cancer
- uterine cancer (squamous cell carcinoma, adeno- and/or adenosquamous cell carcinoma, endometrial carcinoma, carcinosarcoma)
- National Hospital Organization Kobe Medical Center
- 2005-09-09
Other
- Quantification of Epstein-Barr virus DNA in patients undergoing SMILE chemotherapy for stage IV or relapsed/refractory extranodal NK/T-cell lymphoma
- untreated stage IV or relapsed/refractory NK/T-cell lymphoma
- NK-cell Tumor Study Group
- 2007-06-18
Other
- Hypertension Objective Treatment Based on Measurement by Electrical Devices of Blood Pressure (HOMED-BP) Study: Prospective Randomized Open-label Blinded Endpoint (PROBE)
- Untreated essential hypertensive patients
- HOMED-BP Study Group
- 2005-09-09
Other
- Unruptured Cerebral Aneurysm Study in Japan
- Unruptured intracranial aneurysms
- Society of Japan Neurosurgical Society
- 2006-05-17
Other
- ANTI-PLATELET THERAPY FOR COIL EMBOLIZATION OF UNRUPTURED CEREBRAL ANEURYSMS
- Unruptured cerebral aneurysms
- National Cardiovascular Center
- 2005-09-12
Recruiting
- FUTURE study
- Unruptured cerebral aneurysm
- Imamura Hirotoshi
- 2022-01-07
Other
- To evaluate whether two weekly concurrent chemoradiotherapy regimens offer any advantage over concurrent chemoradiotherapy regimens with Cisplatin, Vindesine, Mitomycin for unresectable stage III NSCLC
- unresectable stage III NSCLC
- West Japan Oncology Group
- 2005-08-29
Other
- Randomized phase III study of CPT-11 versus Weekly Paclitaxel for unresectable or recurrent gastric cancer refractory to combination chemotherapy with fluoropyrimidine plus platinum.
- unresectable or recurrent gastric cancer refractory to combination chemotherapy with fluoropyrimidine plus platinum
- West Japan Oncology Group
- 2008-07-15